...
首页> 外文期刊>The Journal of biological chemistry >Interplay between T Cell Receptor Binding Kinetics and the Level of Cognate Peptide Presented by Major Histocompatibility Complexes Governs CD8+ T Cell Responsiveness
【24h】

Interplay between T Cell Receptor Binding Kinetics and the Level of Cognate Peptide Presented by Major Histocompatibility Complexes Governs CD8+ T Cell Responsiveness

机译:T细胞受体结合动力学和主要组织相容性复合物呈递的同源肽之间的相互作用治理CD8 + T细胞响应性

获取原文
           

摘要

Through a rational design approach, we generated a panel of HLA-A*0201/NY-ESO-1157–165-specific T cell receptors (TCR) with increasing affinities of up to 150-fold from the wild-type TCR. Using these TCR variants which extend just beyond the natural affinity range, along with an extreme supraphysiologic one having 1400-fold enhanced affinity, and a low-binding one, we sought to determine the effect of TCR binding properties along with cognate peptide concentration on CD8+ T cell responsiveness. Major histocompatibility complexes (MHC) expressed on the surface of various antigen presenting cells were peptide-pulsed and used to stimulate human CD8+ T cells expressing the different TCR via lentiviral transduction. At intermediate peptide concentration we measured maximum cytokine/chemokine secretion, cytotoxicity, and Ca2+ flux for CD8+ T cells expressing TCR within a dissociation constant (KD) range of ~1–5 μm. Under these same conditions there was a gradual attenuation in activity for supraphysiologic affinity TCR with KD t1/2 = ln 2/koff) values. With increased peptide concentration, however, the activity levels of CD8+ T cells expressing supraphysiologic affinity TCR were gradually restored. Together our data support the productive hit rate model of T cell activation arguing that it is not the absolute number of TCR/pMHC complexes formed at equilibrium, but rather their productive turnover, that controls levels of biological activity. Our findings have important implications for various immunotherapies under development such as adoptive cell transfer of TCR-engineered CD8+ T cells, as well as for peptide vaccination strategies.
机译:通过理性的设计方法,我们产生了HLA-A * 0201 / NY-ESO-1157-165特异性T细胞受体(TCR)的面板,随着野生型TCR的增加至多150倍。使用刚刚超出天然亲和力范围的TCR变体以及具有1400倍增强亲和力的极端超级性,以及低结合,我们寻求确定TCR结合特性以及CD8 +上的同源肽浓度的影响T细胞响应性。在各种抗原呈递细胞表面上表达的主要组织相容络合物(MHC)被肽 - 脉冲,用于刺激通过慢病毒转导的人CD8 + T细胞表达不同TCR。在中间肽浓度下,我们测量最大细胞因子/趋化因子分泌,细胞毒性和CA2 +通量在〜1-5μm的解离常数(Kd)范围内表达TCR。在这些相同的条件下,在具有KD T1 / 2 = LN 2 / koff)值的中枢性亲和力TCR的活动中逐渐衰减。然而,随着肽浓度的增加,表达表达次要亲和力TCR的CD8 + T细胞的活性水平逐渐恢复。我们的数据支持T细胞激活的生产率命中率模型,争论它不是平衡,而是它们的生产性营业额形成的TCR / PMHC复合物的绝对数量,而是控制生物活性水平。我们的研究结果对正在开发的各种免疫治疗具有重要意义,例如TCR工程化CD8 + T细胞的采用细胞转移,以及肽疫苗接种策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号